SEC Tracker
Get the app

Lantheus Holdings LNTH

Lantheus faces FTC review delay

Item 8.01 Other events

Form
8-K
Filed
Importance
Routine
  1. Received Second Request from FTC on Oct 21, 2026
  2. Merger subject to HSR Act waiting period
  3. Parties expect to respond promptly
  4. Merger expected in first half of 2027

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Lantheus Holdings files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2835 and related industry codes: the same peer list as the financial tables.

  1. Adma Biologics ADMA public float $4.2B, Jun 30, 2025
  2. Axsome Therapeutics AXSM public float $4.4B, Jun 30, 2025
  3. Soleno Therapeutics SLNO public float $4.1B, Jun 30, 2025
  4. Halozyme Therapeutics HALO public float $4.5B, Jun 30, 2025
  5. Alkermes ALKS public float $4.7B, Jun 30, 2025